Published in Cancer on June 15, 1990
Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ (2001) 6.08
Breast self-examination: resistance to change. Can Fam Physician (2005) 0.90
Mammography: reviewing the evidence. Epidemiology aspect. Can Fam Physician (1993) 0.89
Breast and prostate cancer. Indian J Clin Biochem (2000) 0.86
Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer. World J Surg (2003) 0.78
Tamoxifen therapy in breast cancer control worldwide. Bull World Health Organ (1993) 0.75
The suggested tasks for Master's graduates in reproductive health by experts in Iran. Iran J Nurs Midwifery Res (2012) 0.75
Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet (1972) 4.36
Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A (1966) 3.56
Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32
Differential binding of the insecticidal lectin GNA to human blood cells. Lancet (1999) 2.39
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun (2010) 2.38
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J Cell Biol (1989) 1.97
A monoclonal antibody to the heavy chain of clathrin. EMBO J (1983) 1.94
Decreased survival related to irradiation postoperatively in early operable breast cancer. Lancet (1974) 1.79
Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol (2009) 1.67
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. Ann Intern Med (1995) 1.59
Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57
Bladder cancer: approaches to prevention and control. Bull World Health Organ (1987) 1.56
Use of pulsed-field gel electrophoresis and flagellin gene typing in identifying clonal groups of Campylobacter jejuni and Campylobacter coli in farm and clinical environments. Appl Environ Microbiol (2001) 1.56
Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ (1984) 1.53
The gene for human complement C9 is on chromosome 5. Genomics (1989) 1.40
Opioid availability in Latin America: the Declaration of Florianópolis. Support Care Cancer (1995) 1.39
Spontaneous mid-trimester uterine rupture in a twin pregnancy. J Obstet Gynaecol (2008) 1.33
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival. Cancer Res (1967) 1.31
Serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors. J Natl Cancer Inst (1971) 1.22
Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax (2008) 1.22
Cranial irradiation in cancer of the lung of all cell types. JAMA (1981) 1.21
A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1. Ann Hum Genet (1985) 1.18
Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology (2012) 1.17
Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples. J Clin Microbiol (2010) 1.11
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team. AIDS Res Hum Retroviruses (2000) 1.11
Heterodimeric transforming growth factor beta. Biological properties and interaction with three types of cell surface receptors. J Biol Chem (1988) 1.08
Gender differences in the risk of familial parkinsonism: beyond LRRK2? Neurosci Lett (2011) 1.07
Age-dependent tumor-host barrier and effect of carcinogen-induced immunodepression on rejection of isografted methylcholanthrene-induced sarcoma cells. J Natl Cancer Inst (1966) 1.05
Effect of noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro. J Natl Cancer Inst (1966) 1.03
Tumour-distinctive cellular immunity to renal carcinoma. Clin Exp Immunol (1970) 1.03
Prevalence of nim genes in anaerobic/facultative anaerobic bacteria isolated in South Africa. FEMS Microbiol Lett (1999) 1.02
Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis (2000) 1.02
Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma. Cancer (1977) 1.02
Immunological changes after radiotherapy for mammary carcinoma. Ann Inst Pasteur (Paris) (1972) 1.02
The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrinol (1993) 1.01
Isolation and sequence of a full length cDNA encoding a novel rat inositol 1,4,5-trisphosphate 3-kinase. Biochim Biophys Acta (1994) 1.01
Immune status of the primary host toward its own methylcholanthrene-induced sarcomas. J Natl Cancer Inst (1968) 1.00
Constitutive phosphorylation of the epidermal growth factor receptor blocks mitogenic signal transduction. J Biol Chem (1991) 1.00
Letter: Postoperative radiotherapy and breast cancer. Lancet (1976) 1.00
Further immunological studies of chemical carcinogenesis. J Natl Cancer Inst (1967) 0.99
Integration of Ecogpt and SV40 early region sequences into human chromosome 17: a dominant selection system in whole cell and microcell human-mouse hybrids. EMBO J (1983) 0.99
Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial. Cancer (1981) 0.98
Immunodepressive effect of 3-methylcholanthrene. Antibody formation at the cellular level and reaction against weak antigenic homografts. J Natl Cancer Inst (1965) 0.98
The 68 kDa protein of signal recognition particle contains a glycine-rich region also found in certain RNA-binding proteins. FEBS Lett (1990) 0.97
Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG (2006) 0.97
Chromosome mapping of cell membrane antigens expressed on activated B cells. Eur J Immunol (1985) 0.96
Anaplastic giant-cell carcinoma of the thyroid. A study of treatment and prognosis. Cancer (1975) 0.94
Impact of age and sex on mycobacterial immunity in an area of high tuberculosis incidence. Int J Tuberc Lung Dis (2010) 0.94
Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Cancer Res (1967) 0.92
Perforin. A family of killer proteins. Nature (1988) 0.92
Cellular immunity to human sarcoma. J Natl Cancer Inst (1971) 0.92
Effect of hysterectomy on anorectal and urethrovesical physiology. Gut (1992) 0.91
Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site. J Biol Chem (1992) 0.90
Adjuvant radiotherapy trials in breast cancer. Cancer (1977) 0.89
Lung cancer--a worldwide health problem. Chest (1989) 0.89
Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1980) 0.89
Tumor-distinctive cellular immunity to human sarcoma and carcinoma. Isr J Med Sci (1971) 0.89
Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction. Int J Cancer (1974) 0.89
Cellular immunity to nephroblastoma. Int J Cancer (1971) 0.88
Age-dependent rise and fall of immunological reactivity in the CBA mouse. J Natl Cancer Inst (1966) 0.87
Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase. Blood (1998) 0.87
Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection? AIDS Res Hum Retroviruses (2001) 0.87
Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial. Cancer (1978) 0.87
Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes. Diabet Med (2010) 0.86
Chromosome assignment of monoclonal antibody-defined determinants on human leukemic cells. Eur J Immunol (1983) 0.86
A statistical analysis of murine stem cell suicide techniques. Blood (1980) 0.85
Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS). Int J Cancer (1978) 0.85
Clinical trials in neuro-oncology. Curr Opin Neurol (2001) 0.85
Immunosuppression by carcinogens. Antibiot Chemother (1969) 0.84
Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG). J Acquir Immune Defic Syndr (1994) 0.84
Mutational removal of the major site of serine phosphorylation of the epidermal growth factor receptor causes potentiation of signal transduction: role of receptor down-regulation. Mol Endocrinol (1992) 0.83
Patterns of failure in patients with inoperable carcinoma of the lung. Cancer (1981) 0.83
Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK. J Antimicrob Chemother (2000) 0.82
An overview of the situation in radiotherapy with emphasis on the developing countries. Int J Radiat Oncol Biol Phys (1990) 0.81
Tumor-associated specificity of serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors. J Natl Cancer Inst (1973) 0.81
Stimulation of lymphocytes by autochthonous cancer. Natl Cancer Inst Monogr (1972) 0.80
Indication of tumour specific cell-bound immunological reactivity and depressed general reactivity in a pair of twins. Clin Exp Immunol (1970) 0.80
Effect of bacillus Calmette-Guérin and/or methylcholanthrene on the antibody-forming cells measured at the cellular level by a hemolytic plaque test. Cancer Res (1966) 0.80
Rebuttal of two articles by Dr. Levitt et al. Cancer 1977. Cancer (1978) 0.80
Delayed hypersensitivity-induced regression of human neoplasms. Cancer (1971) 0.79
Studies in the transplantation of allogeneic cartilage across known histocompatibility barriers. Bibl Haematol (1965) 0.79
Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors. Int J Cancer (1975) 0.79
Introduction: Modification of immunity and carcinogenesis. Natl Cancer Inst Monogr (1972) 0.79
Cancers of the stomach, lung and breast: mortality trends and control strategies. World Health Stat Q (1988) 0.78
Comparison of chemotherapy alone versus chemotherapy and radiation therapy of extensive small cell carcinoma of the lung. J Surg Oncol (1983) 0.78
Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease. Parkinsonism Relat Disord (2012) 0.78
Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma patients. J Natl Cancer Inst (1973) 0.78
Characterization of maleuric acid derivatives on transgenic human monoclonal antibody due to post-secretional modifications in goat milk. Biomed Chromatogr (2006) 0.78
Regression of primary malignant melanoma associated with a good prognosis despite metastasis to lymph nodes. Rev Eur Etud Clin Biol (1970) 0.77
N-glycans are not a universal signal for apical sorting of secretory proteins. FEBS Lett (1999) 0.77
The gene for the human putative apoE receptor is on chromosome 12 in the segment q13-14. Genomics (1989) 0.76
Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro. J Natl Cancer Inst (1967) 0.76
Catalonia WHO Demonstration Project on Palliative Care Implementation 1990-1995: results in 1995. J Pain Symptom Manage (1996) 0.76
Lymphocyte stimulation by autochthonous human solid tumours. Br J Cancer Suppl (1973) 0.75
Cancer control: introduction to a series of reports on strategies and approaches. Bull World Health Organ (1986) 0.75